vs
Doximity, Inc.（DOCS）与NEOGENOMICS INC（NEO）财务数据对比。点击上方公司名可切换其他公司
NEOGENOMICS INC的季度营收约是Doximity, Inc.的1.0倍（$186.7M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs -57.9%，领先91.1%），NEOGENOMICS INC同比增速更快（11.1% vs 9.8%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 6.5%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
DOCS vs NEO — 直观对比
营收规模更大
NEO
是对方的1.0倍
$185.1M
营收增速更快
NEO
高出1.3%
9.8%
净利率更高
DOCS
高出91.1%
-57.9%
两年增速更快
DOCS
近两年复合增速
6.5%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $186.7M |
| 净利润 | $61.6M | $-108.0M |
| 毛利率 | 89.9% | 43.3% |
| 营业利润率 | 38.9% | 46.9% |
| 净利率 | 33.3% | -57.9% |
| 营收同比 | 9.8% | 11.1% |
| 净利润同比 | -18.1% | 42.0% |
| 每股收益（稀释后） | $0.31 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSNEO
| Q1 26 | — | $186.7M | ||
| Q4 25 | $185.1M | $190.2M | ||
| Q3 25 | $168.5M | $187.8M | ||
| Q2 25 | $145.9M | $181.3M | ||
| Q1 25 | $138.3M | $168.0M | ||
| Q4 24 | $168.6M | $172.0M | ||
| Q3 24 | $136.8M | $167.8M | ||
| Q2 24 | $126.7M | $164.5M |
净利润DOCSNEO
| Q1 26 | — | $-108.0M | ||
| Q4 25 | $61.6M | — | ||
| Q3 25 | $62.1M | $-27.1M | ||
| Q2 25 | $53.3M | $-45.1M | ||
| Q1 25 | $62.5M | $-25.9M | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $44.2M | $-17.7M | ||
| Q2 24 | $41.4M | $-18.6M |
毛利率DOCSNEO
| Q1 26 | — | 43.3% | ||
| Q4 25 | 89.9% | 43.8% | ||
| Q3 25 | 90.3% | 42.8% | ||
| Q2 25 | 89.2% | 42.6% | ||
| Q1 25 | 89.5% | 43.6% | ||
| Q4 24 | 91.6% | 44.9% | ||
| Q3 24 | 90.0% | 44.6% | ||
| Q2 24 | 89.3% | 44.1% |
营业利润率DOCSNEO
| Q1 26 | — | 46.9% | ||
| Q4 25 | 38.9% | -7.1% | ||
| Q3 25 | 37.8% | -14.4% | ||
| Q2 25 | 37.4% | -26.3% | ||
| Q1 25 | 35.2% | -16.6% | ||
| Q4 24 | 47.4% | -10.7% | ||
| Q3 24 | 38.8% | -12.6% | ||
| Q2 24 | 36.4% | -13.3% |
净利率DOCSNEO
| Q1 26 | — | -57.9% | ||
| Q4 25 | 33.3% | — | ||
| Q3 25 | 36.8% | -14.4% | ||
| Q2 25 | 36.5% | -24.9% | ||
| Q1 25 | 45.2% | -15.4% | ||
| Q4 24 | 44.6% | — | ||
| Q3 24 | 32.3% | -10.5% | ||
| Q2 24 | 32.7% | -11.3% |
每股收益（稀释后）DOCSNEO
| Q1 26 | — | $-0.13 | ||
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | — | ||
| Q2 25 | $0.27 | — | ||
| Q1 25 | $0.31 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.22 | — | ||
| Q2 24 | $0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $146.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $979.3M | $828.8M |
| 总资产 | $1.2B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCSNEO
| Q1 26 | — | $146.1M | ||
| Q4 25 | $64.8M | $159.6M | ||
| Q3 25 | $169.2M | $164.1M | ||
| Q2 25 | $137.3M | $154.7M | ||
| Q1 25 | $209.6M | $346.2M | ||
| Q4 24 | $165.3M | $367.0M | ||
| Q3 24 | $184.2M | $362.0M | ||
| Q2 24 | $111.4M | $355.1M |
总债务DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | — | $341.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $541.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益DOCSNEO
| Q1 26 | — | $828.8M | ||
| Q4 25 | $979.3M | $836.6M | ||
| Q3 25 | $1.1B | $838.3M | ||
| Q2 25 | $1.0B | $854.0M | ||
| Q1 25 | $1.1B | $888.3M | ||
| Q4 24 | $1.0B | $902.3M | ||
| Q3 24 | $961.2M | $908.2M | ||
| Q2 24 | $913.6M | $915.9M |
总资产DOCSNEO
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B |
负债/权益比DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $-8.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCSNEO
| Q1 26 | — | $-8.1M | ||
| Q4 25 | $60.9M | $1.3M | ||
| Q3 25 | $93.9M | $8.9M | ||
| Q2 25 | $62.1M | $20.3M | ||
| Q1 25 | $98.5M | $-25.3M | ||
| Q4 24 | $65.2M | $9.8M | ||
| Q3 24 | $68.3M | $9.2M | ||
| Q2 24 | $41.2M | $13.9M |
自由现金流DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | — | $-6.5M | ||
| Q3 25 | — | $570.0K | ||
| Q2 25 | — | $14.0M | ||
| Q1 25 | — | $-29.8M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | — | $814.0K |
自由现金流率DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | -17.8% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | 0.5% |
资本支出强度DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | 0.0% | 2.7% | ||
| Q4 24 | 0.0% | 6.7% | ||
| Q3 24 | 0.0% | 6.4% | ||
| Q2 24 | 0.0% | 8.0% |
现金转化率DOCSNEO
| Q1 26 | — | — | ||
| Q4 25 | 0.99× | — | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
NEO
暂无分部数据
